Marina Kremyanskaya
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm (NCT05025488) | Marina Kremyanskaya | 2023-04-04 |
| Ruxolitinib in Combination With Autotransplant (NCT02469974) | Marina Kremyanskaya | 2015-05-01 |
Track Marina Kremyanskaya automatically
Every clearance here is in the API, with alerts when new ones post.